Dermapen

Dermapen offers unrivalled needling innovation with its original, exclusive and patented technology.

Only Dermapen's unique spring-loaded Microderm Needle Cartridge uses electrically charged automation to revolutionise skin needling procedures. The oscillating stamp-like pen (with AOVN technology) harmoniously vibrates and glides over the skin providing the most efficient control, safety and comfort possible, whilst delivering treatment in the shortest time frame. With 12 needles in each tip and a motor which is capable of 108 Hz, the Dermapen produces around 1300 micro channels per second.

Each disposable Microderm Needle Cartridge is individually gamma-sterilised and packaged for effortless loading and replacement into the Dermapen device. For the ulimate in skin compatibility, the needles are solely manufactured from surgical grade stainless steel naturally reinforced with molybdenum and chromium for increased durability, strength and performance. The needles are free of nickel and titanium and may be tolerated by even the most allergic of skins. The Microderm Needle Cartridge may be adjusted anywhere from 0.0mm-2.5mm (depending on the device), creating procedual versatility that can actually be modified during treatment to accommodate skin thickness and area location whilst administering customised condition focus. Dermapen's characteristic pen size allows easy manoeuvrability around facial and body contours, including traditionally harder-to-treat areas around the lower eyes, beneath the eyebrow, corners of the nose and the peri-oral contours.

The electrically charged automation powered by a high duty cycle motor (with AOVN technology) reduces epidermal damage, discomfort and procedural downtime. The motor offers a multiple speed option for greater control and treatment versatility. Unlike needling rollers, where the needles are inserted at a 45-90 degree angle (promoting increased pain and unnecessary epidermal damage), Dermapen's vertical vibrating mechanism disipates nerve response and ensures that the skin is gently stamped vertically (at 90 degrees, providing treatment consistency without compromising tissue integrity. Dermapen's vertical needle insertion also removes the risk of needles bending with the skin, along with uneven depth entry and control - some common problems created by other needling technologies.

Features & Benefits

The electrically charged automation.

Skin Histology / Physiology & Dermapen

As the Dermapen is gently guided and glided over the skin, microscopic puncture channels are lightly stamped into the skin's matrix stimulating an inflammatory, or wound healing response. This promotes intense renewal, repair and rejuvenation. Natural growth factors are released to stimulate reformation and deposition of fresh restructuring collagen. Unlike most skin rejuvenation treatments, Dermapen directly targets three major cell types (keratinocytes, melanocytes and fibroblasts) and promotes scarless wound healing via a controlled wound healing response. The risk of irregular fibrotic collagen deposition is virtually removed.

The skin is composed of three major layers each containing major cell groups: hypodermis, dermis and epidermis. Such groups are directly and indirectly targeted by a dermapend clinical procedure, depending on the needle depth chosen. the epidermis and the dermis are the key skin layers to be targeted by a Dermapen clinical treatment.

Inflammatory / Wound Healing Response & Dermapen

The Inflammatory Response is defined by five distinct features:

• Dolor (pain)
• Calor (heat)
• Rubor (erythema)
• Tumour (oedema)
• Functio Laesa (loss of function)

and is the skin's initial response to superficial or acute micro trauma. Superficial treatment of the epidermis during a Dermapen procedure will stimulate an inflammatory response, as opposed to a wound healing response. Depending on the condition being treated, this may enable closer treatment intervals.

The Wound Healing Response is defined by:

The biological repair action that cascades within the skin after chronic or deeper micro trauma. Whilst the process is commonly categorised into three distinct functions: Inflammation, Proliferation and Maturation, the protential creation of pinpoint bleeding during a Dermapen procedure creates the addition of Haemorrhage / Haemostasis as a processional starting point. Dermapen's non-thermoltic and non-ablative technology ensures controlled wound healing stimulated fibroblast division and the deposition of tightly woven collagen fibres.

Dermapen's controlled effect on the wound healing response enables treatment on all Fitzpatrick skin types and can be effective on skins prone to fibrotic tissue production. Trauma created via the destruction of the epidermis with ablative technologies, dermabrasion, or deep chemical peels can often result in thinning of the epidermis, a loss of dermal papillae and damage to melanocytes (creating post-inflammatory hyperpigmentation). Abnormal healing may further be aggressed via the thermolytic action activated by ablative and non-ablative laser and intense pulsed light (IPL). Complications include cicatricial healing, the inactivation of certain growth factors due to coagulation and the release of pro-fibrotic growth factors (including transforming growth factor B1 & B2), vascular endothelial growth factor (VEGF), lumphotoxin B and heat shock protein 47.

Overstimulation of fibroblasts via heat and inflammation can create an overproduction of scar-type connective tissue. Type III Collagen produced via the wound healing response matures and is replaced by Type I Collagen at an inconsistently faster rate. If phagotised particles are insufficiently digested and destroyed during the inflammatory process, granulomatous inflammation may develop where granulomas can form creating fibrotic tissue. The results of Dermapen regulate and balance this process ensuring seamless, scarless healing with virtually no risk of post-inflammatory hyperpigmentation.

Dermapen Clinical Treatment Indications

Dermapen provides effective management for most skin conditions, allowing simultaneous treatment of multiple concerns (via adjustable needle depth and oscillation speed). Dermapen clinical devices are all suitable for face, body and head applications.

Results may be seen after just one procedure. A condition specific and tailored treatment plan should be designed and prescribed during patient consultation.

Patient treatment programmes are influenced by:

• The conditions being treated
• The location of the condition
• How long the condition has been active
• What a combination therapies (if any) are to be utilised

Each skin response is unique. A professional consultation will establish:

• Clinical treatment intervals
• What needle depths are to be used
• How many treatments in total may be required

A Dermapen Clinical Treatment Consultation & Consent Form should be completed by the patient prior to consultation.

By cascading the skin's natural healing response, a Dermapen clinical procedure delivers increased cellular proliferation and regeneration, whilst stimulating angiogenesis, increasing collagen and glycosaminoglycan production and regulating melanogenesis. The skin becomes cumulatively re-texturised, rejuvenated and restructured, minimising the appearance of ageing, uneven skin tone, uneven texture, imperfections and areas of indentation. Results may be seen even after one treatment.

Treatment Recovery & Post-Operative Care

Dermapen's vertical needle insertion and adjustable needle depth ensures the fastest recovery period of any skin needling modality. Active results may be achieved whilst simultaneously promoting effective skin correction.

After a Dermapen procedure you may experience:

• Erythema similar to the appearance and sensation of mild sunburn is an indication of succesful treatment.
• Dermapen's unique application ensures that there are no signs of bruising, grazing, track marks, scabbing or laceration to the treated area.
• The 33 gauge needle puncture channels created during a Dermapen treatment typically constrict within 7-15 minutes.
• Petechiae may appear on areas of thin or more delicate skin especially around the peri-orbital area.
• Pinpoint bleeding can be expected and is very minimal in most cases.
• Patients on anti-coagulant medications or supplements will be more prone to pinpoint bleeding and petechiae. Whilst bleeding is haemorrhaged within minutes during treatment, petechiae may last for 2-3 days before eventually dissolving.
• Some patients may experience minor itching or swelling on the treated areas following a dermpen procedure. This may occur from accelerated cellular desquamation, or in very rare cases may be a minio skin reaction to certain topical local anaesthetic actives.

The Typcial Recovery Timeline Post-Treatment is Defined by:

Patients should allow 45-90 minutes for their appointment. This includes a full consultation, skin assessment, Dermapen procedure and post procedure care. Patients may resume work or normal activity almost immediately post-treatment.

Patients are advised to avoid the following activities and practices for at least 2 days post-procedure:

• Direct ultra violet exposure (sun and solariums)
• Intensive cardio, exercise or gymnasium regimens
• Further clinical treatments (including, but not limited to): microdermabrasion, laser, intense pulsed light (IPL), chemical peels, muscle relaxant injections and dermal fillers)
• Tattooing (including cosmetic tattooing)
• Applying high dosages of active topical skin care ingredients (including, but not limited to): retinoids, hydroquinone, alpha-hydroxy-acids, beta-hydroxy-acids, benzoyl peroxide, alcohol (ethanol/isopropyl), chemical based sunscreens.
• Excessively hot showers, bathing, spas, saunas or steam rooms
• Spray or self-tanning
• Swimming in chlorinated pools or the ocean

Patients prone to herpes simplex (cold sores), are recommended to take or apply a targeted prophylaxis such as acyclovir to prevent a possible outbreak prior to treatment.

During the recovery period, patients are recommended to use a mild, soap-free, pH balanced cleanser that will not strip, irritate or leave a heavy residue on the skin. A gentle exfoliant may be diluted with water to gently cleanse the skin daily. Use of non-active, non-occlusive and non-comedogenic nourishing and protective serums and moisturisers is recommended to be applied as often as necessary to reduce inflammation, restore skin comfort and accelerate the healing process. A gentle broad-spectrum sunscreen should be worn and re-applied as required daily. Your practitioner will be able to advise on pre and post skin care during your consultation.

Dermapen Treatment Contra-indications

Patients experiencing any of the following active conditions should not proceed with a dermapen treatment:

• Papulopustular rosacea
• Acne vulgaris stage III-IV
• Herpes simplex
• Warts
• Scleroderma
• Bacterial / fungal infections
• Open lesions
• Solar Keratosis
• Skin cancer
• Haemophilia

If you have any further questions, please do not hesitate to contact us and we will be happy to answer and assist you with your enquiries.

Book a complimentarty consultation today! Click here for our Terms & Conditions.